Research / Study Back to all studies Completed NCT01398865
Escitalopram Neuroimaging Supplement This study is completed. It focuses on body dysmorphic disorder and currently lists study information in the United States.
Body dysmorphic disorder Observational From 18 Years to 64 Years
Condition focus Body dysmorphic disorder
Countries United States
Status Completed
Registry ClinicalTrials.gov
Study type Observational i A study where researchers collect information without assigning a treatment.
Study design Observational i A study where researchers collect information without assigning a treatment.
Age eligibility From 18 Years to 64 Years
Sponsor Massachusetts General Hospital The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English Key information made simple What is this study testing? This observational study follows adults living with body dysmorphic disorder to understand their experience, outcomes, or changes over time.
What would participation involve? Participants may complete imaging scans, attend study visits with the research team. The registry lists locations in the United States.
Who is it mainly for? This study appears to be mainly for adults with body dysmorphic disorder.
What should you check before joining? Ask about whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step Check the study details Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab) Recruitment and eligibility Is a site open, and who can take part?
Visits and time Where are visits, can any be remote, and how much time is needed?
Costs and support What costs, reimbursement or compensation apply?
Before joining Questions to ask before joining What are the exact eligibility criteria, and what could exclude someone? How many visits, assessments, or follow-ups are expected, and over what period? What risks, side effects, practical burdens, or alternatives should be understood first? Who should be contacted to confirm locations, timing, compensation, and next steps? Study clarity Things to check before joining Study start date December 2008
Recruitment status Completed
Enrollment listed in the registry 23
Sponsor Massachusetts General Hospital
Sponsor type Hospital / academic medical center
Study type Observational
Intervention type PROCEDURE
Study phase Not clearly listed
Locations United States
Age range From 18 Years to 64 Years
Official registry ID NCT01398865
Official title Cerebral Metabolic Correlates of Treatment Response to Escitalopram in Body Dysmorphic Disorder Ask HopeStage to help me review this study This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT01398865. We help you review the study, but cannot decide medical eligibility.
Registry details Registry conditions (original wording) Body Dysmorphic Disorder
FAQ Questions about this study Who is behind this study? The study sponsor is Massachusetts General Hospital.
Who can participate? Listed age limits: 18 years to 64 years.
Is this study still recruiting? The registry lists this study as completed.
Explore other studies Want to find a study that may fit you better? Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me 
